1.
tissue thromboplasti
组织促凝血酶原激酶
2.
thromboplastin antecedent
促凝血酶原激酶先质
3.
plasma throml oplastin antecedant (PTA)
血浆促凝血酶原激酶前体
4.
An enzyme in human urine that catalyzes the conversion of plasminogen to plasmin and is used in medicine to dissolve blood clots.
尿激酶人体尿液中的可促使血将酶原转代成血浆酶的酶，用于溶解血凝块的药物中
5.
Nucleocapsid Protein of SARS-associated Coronavirus Upregulates the Transcription of hfgl2 Prothrombinase/ Fibroleukin Gene;
SARS冠状病毒N蛋白激活hfgl2凝血酶原酶基因的研究
6.
congenital aprothrombinemia
先天性凝血酶原缺乏症
7.
Influence of Aprotinin to Activated Clotting Time and Whole Blood Prothrombin Time during Cardiopulmonary Bypass;
体外循环下抑肽酶对激活的全血凝固时间和全血凝血酶原时间的影响
8.
an enzyme that acts on fibrinogen in blood causing it to clot.
血液中一种通过与纤维蛋白原反应而促进血凝固的酶。
9.
Use of EDTA Samples for Prothrombin time Measurement
使用EDTA抗凝血检测凝血酶原时间
10.
Clinical Research on Activation of Platelet and Prothrombin after Transcatheter Closure of Atrial Septal Defects;
房间隔缺损封堵术后血小板活化和凝血酶原激活临床研究
11.
Role of Phosphatidylinositol 3-Kinase and Myosin Light Chain Kinase during the Activation of Thrombin Receptors
凝血酶信号传导过程中PI3-K与MLCK激酶的作用
12.
Analysis of the Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Fibrinogen in Patients with Coronary Atherosclerotic Heart Disease
冠心病患者凝血酶激活的纤溶抑制物与纤维蛋白原关系分析
13.
Electrophysiological evaluation of the safety of injection of tissue plasminogen activator into optic nerve in rabbits
视盘内注射组织凝血酶原激活剂安全性的电生理学评价(英文)
14.
Effect of Erythropoietin on Neuronal Apoptosis and Glycogen Synthase Kinase-3β Expression in Newborn Rats with Hypoxic-Ischemic Brain Damage
促红细胞生成素对缺氧缺血性脑损伤新生大鼠细胞凋亡和糖原合成酶激酶-3β的影响
15.
Prokaryotic Expression,Purification and Procoagulant Activity Analysis of Recombinant Fibrinogen-related Domain Protein of Human fgl2 Prothrombinase
人fgl2凝血酶原酶FRED结构域的原核表达、纯化及其凝血活性的鉴定
16.
3D-QSAR study for novel inhibitors of mitogen activated protein kinase-activated protein kinase 2
促分裂原活化蛋白激酶激活的蛋白激酶-2全新抑制剂的3D-QSAR研究
17.
The precursor of any of various blood factors necessary for coagulation.
前凝血剂血液凝结所必须的凝血因子的凝血酶原
18.
The Influence of Different Thromboplastins Upon the International Normalised ratio (INR) and the Prothrombin Time Ratio (PTR)
组织凝血活酶对凝血酶原时间比率与国际正常化比率的影响